Guidelines for preclinical animal research in ALS/MND: A consensus meeting-Reference-Cited by-同舟云学术

Guidelines for preclinical animal research in ALS/MND: A consensus meeting

Published:2010-01 Issue:1-2 Volume:11 Page:38-45
ISSN:1748-2968
Container-title:Amyotrophic Lateral Sclerosis
language:en
Short-container-title:Amyotrophic Lateral Sclerosis

Author:

Ludolph Albert C.,Bendotti Caterina,Blaugrund Eran,Chio Adriano,Greensmith Linda,Loeffler Jean-Philippe,Mead Richard,Niessen Heiko G.,Petri Susanne,Pradat Pierre-Francois,Robberecht Wim,Ruegg Markus,Schwalenstöcker Birgit,Stiller Detlev,van den Berg Leonard,Vieira Fernando,von Horsten Stephan

Publisher

Informa UK Limited

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/17482960903545334

Reference19 articles.

1. Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: Report on the 142nd ENMC international workshop

2. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

3. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

4. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

5. Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nurturing hope: Uncovering the potential of herbal remedies against amyotrophic lateral sclerosis;PharmaNutrition;2024-09

2. Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis;Expert Opinion on Biological Therapy;2024-08-23

3. Effect of ultrasound-mediated blood-spinal cord barrier opening on survival and motor function in females in an amyotrophic lateral sclerosis mouse model;eBioMedicine;2024-08

4. Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models;Neurotherapeutics;2024-04

5. PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS;PLOS ONE;2024-02-15